Related Experiment Video
Updated: Jun 11, 2026
07:37
Isolation and Characterization of Extracellular Vesicles from Adult Schistosoma japonicum
Published on: May 22, 2018
Schistosomiasis japonica control and research needs
Xiao-Nong Zhou1, Robert Bergquist, Lydia Leonardo
1National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Shanghai, People's Republic of China.
Advances in Parasitology
|July 14, 2010
Summary
Integrated control strategies are crucial for managing schistosomiasis japonica (caused by Schistosoma japonicum). Adapting interventions is key to controlling and eliminating this parasitic disease.
Area of Science:
- Medical Entomology
- Tropical Medicine
- Parasitology
Background:
- Schistosomiasis japonica, caused by Schistosoma japonicum, remains a significant public health issue in parts of Asia.
- Despite control efforts, the disease is re-emerging in some endemic regions, necessitating updated strategies.
Purpose of the Study:
- To review the epidemiological status and transmission patterns of Schistosomiasis japonica.
- To analyze national control efforts and extract lessons learned for disease management.
- To emphasize the need for innovative and adaptive control approaches for elimination.
Main Methods:
- Review of epidemiological data and transmission dynamics.
- Historical analysis of control programs in endemic countries.
- Evaluation of integrated control approaches and intersectoral collaboration.
Main Results:
- An integrated, intersectorally collaborative approach is essential for reducing Schistosoma japonicum infection prevalence and intensity.
- Sustained low levels of infection require flexible and adaptive intervention strategies.
- Lessons learned from national control efforts highlight the importance of adapting to evolving challenges.
Conclusions:
- Integrated control and intersectoral collaboration are vital for managing Schistosomiasis japonica.
- Flexible and innovative approaches are necessary to move from morbidity control to elimination.
- Experiences from China, the Philippines, and Indonesia offer valuable insights for global schistosomiasis control efforts.
Related Concept Videos
01:22American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
01:30Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
01:18Trichomoniasis
Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...